Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
Neurosurgical Focus|December 2, 2016
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomasMatteo Zoli, Luisa Sambati, Laura Milanese, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2024
Spatial Cancer-Immune Phenotypes Predict Shorter Recurrence-Free Survival in the No Specific Molecular Profile Molecular Subtype of Endometrial CarcinomaDario de Biase, Jacopo Lenzi, Claudio Ceccarelli, et al.World Journal of Gastroenterology|June 17, 2021
Molecular alterations in pancreatic tumorsMichela Visani, Giorgia Acquaviva, Antonio De Leo, et al.Oncotarget|February 9, 2018
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid CarcinomasGreta Gandolfi, Moira Ragazzi, Dario de Biase, et al.International Journal of Molecular Sciences|February 25, 2023
Expanding the Spectrum of <i>BRAF</i> Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral CentreAntonio De Leo, Daniela Serban, Thais Maloberti, et al.Endocrine|January 17, 2025
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literatureKimberly Coscia, Caterina Ravaioli, Lorenzo Tucci, et al.Critical Reviews in Oncology/Hematology|January 21, 2015
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncologyAlba A Brandes, Marco Bartolotti, Gianluca Marucci, et al.Cancers|January 23, 2020
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk StratificationGiovanni Tallini, Antonio De Leo, Andrea Repaci, et al.Journal of Neuro-Oncology|November 5, 2014
Post progression survival in glioblastoma: where are we?Enrico Franceschi, Mario Ermani, Stefania Bartolini, et al.European Thyroid Journal|June 20, 2025
Molecular predictive biomarker testing in advanced thyroid cancer - a European consensusAleš Ryška, Jaume Capdevila, Matthias S Dettmer, et al.Pageof 22